Exclusive Interview with PharmaShots: Kevin Cammack and Mark Warren Share Insight on Lyumjev U-100 Approved for Use in Insulin Pumps

In an interview with PharmaShots, Kevin Cammack, Head of Connected Care, Eli Lilly, and Mark Warren, MD, Director of Endocrine Clinical Trials and Laboratory Services, Physicians East share their views on the US FDAs approval of rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2…

BySenior EditorOctober 4, 2021

Announcements

PharmaShots Celebrates Successful Accomplishment of Three Years

Shots: PharmaShots has started its journey in July 2018 as a concise, real-time news delivery platform and is proud to announce the completion of three years, with many more to come. Till now, PharmaShots has published 5,000+ posts with 10000+ subscribers With the completion of three years journey, PharmaShots is proud to announce the PharmaShots App to…

BySenior EditorJuly 25, 2021

EVENTS

12th Summit on Biosimilars & Innovator Biologics

June 22 ' 23, 2021 (EDT) | Virtual Conference The American Conference Institute invites you to attend the Virtual 12th Summit on Biosimilars & Innovator Biologics on June 22-23, 2021! Gain government and industry insights on the Innovator and Biosimilars Marketplace from the U.S. FTC, U.S. FDA, USPTO, and leading In-House Counsel. As the number…

BySenior EditorApril 30, 2021

INSIGHTS+

PharmaShots’ Key Highlights of First Quarter 2021

The first quarter of 2021 highlights new approvals, M&A, and the clinical data of COVID-19 vaccines. The companies expand their working in COVID-19 by targeting South African & Brazil variants along with other emerging variants Starting with the latest acquisition, Amgen acquired Five Prime for $1.9B, Jazz acquired JW while Boston acquired Preventice. This quarter…

ByRidhi RastogiApril 4, 2021

THOUGHTSPOT

Wearables in the Market & their Roles

Wearables are electronic devices consisting of sensors that can receive data of user's personal health and exercise schedules. They work wirelessly or with the help of other devices such as smartphones, tablets, or laptops. The market of wearable technology was valued at $15.74 billion in 2015 & expected to extend $51.60 billion by 2022 at…

ByParshuram NivruttiFebruary 9, 2021

INSIGHTS+

PharmaShots’ Key Highlights of Fourth Quarter 2020

The fourth quarter of 2020 contains multiple initiations of clinical trials, big approvals, and numerous deals. COVID-19 related news remains at the peak in this quarter Multiple companies received regulatory bodies EUA for their vaccines and treatments for COVID-19. Initiating with, Regeneron sought the US FDA's EUA for REGN-COV2 Ab combination while Health Canada accelerated…

ByDipanshu DixitJanuary 14, 2021

VIEWPOINTS

PharmaShots Interview: Janssen’s Kiran Patel Shares Insights on Amivantamab for Metastatic EGFR Exon 20+ NSCLC

In a recent interview with PharmaShots, Kiran Patel, Vice President Clinical Development, Solid Tumor Franchise at Janssen shared his views on the regulatory submission of Amivantamab for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Shots: Janssen reported the BLA submission to the US FDA seeking approval of Amivantamab for the…

BySenior EditorJanuary 13, 2021

EVENTS

Exclusive Webinar: Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem

Shots: Intellimed in collaboration with alpha MD & IMPA along with PharmaShots as the media partner is gladly organizing a webinar on 'Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem' The objective of the webinar is to discuss the need for affordable healthcare in India and the…

BySenior EditorJanuary 13, 2021

Announcements

PharmaShots Wishes you a Merry Christmas and a Happy New Year

Shots: Thank you for your overwhelming affection and support throughout the year. This year we achieved a massive increase in subscribers PharmaShots mobile app is ready and we planned to launch our PharmaShots mobile app in January 2021 May this holiday season fills your life with happiness and wealth. Wish you a Merry Christmas and…

BySenior EditorDecember 24, 2020

VIEWPOINTS

PharmaShots Interview: FibroGen’s Peony Yu Shares Insight on Roxadustat

In a recent interview with PharmaShots, Peony Yu, Chief Medical Officer of FibroGen shared her insights and highlights on data of Roxadustat Shots: FibroGen presented new efficacy and safety analyses from the roxadustat global P-III program at ASN Kidney Week 2020 Reimagined. FibroGen and its partners, AstraZeneca and Astellas, presented 42 abstracts, including 2 late-breaker poster presentations,…

BySenior EditorDecember 7, 2020

Exclusive Interview with PharmaShots: Kevin Cammack and Mark Warren Share Insight on Lyumjev U-100 Approved for Use in Insulin Pumps

PharmaShots Celebrates Successful Accomplishment of Three Years

12th Summit on Biosimilars & Innovator Biologics

PharmaShots’ Key Highlights of First Quarter 2021

Wearables in the Market & their Roles

PharmaShots’ Key Highlights of Fourth Quarter 2020

PharmaShots Interview: Janssen’s Kiran Patel Shares Insights on Amivantamab for Metastatic EGFR Exon 20+ NSCLC

Exclusive Webinar: Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem

PharmaShots Wishes you a Merry Christmas and a Happy New Year

PharmaShots Interview: FibroGen’s Peony Yu Shares Insight on Roxadustat

Contact US

FOLLOW US